Jina PharmaceuticalsOrganizationGet new research by emailTrialsA Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer PatientsPhase 3, Recruiting, 657 people, Sep 14, 2018Sources: clinicaltrials.gov